Table 1 Demographics of study population
Variable | Total cohort n = 649 (%) | Severe bleed n = 226 (%) | Non-severe bleed n = 423 (%) | P value |
|---|---|---|---|---|
Mean age, y (± SD) | 67.3 (15.2) | 68.3 (15.0) | 66.7 (15.3) | 0.65 |
< 60 | 180 (27.7) | 59 (26.1) | 121 (28.6) | |
≥ 60 | 469 (72.3) | 167 (73.9) | 302 (71.4) | 0.50 |
Gender | ||||
Male | 351 (54.1) | 121 (53.5) | 230 (54.4) | 0.84 |
Female | 298 (45.9) | 105 (46.5) | 193 (45.6) | |
Race | ||||
Chinese | 576 (88.8) | 203 (89.8) | 373 (88.2) | 0.053 |
Malay | 40 (6.2) | 18 (8.0) | 22 (5.2) | |
Indian | 16 (2.5) | 3 (1.3) | 13 (3.1) | |
Others | 17 (2.6) | 2 (0.9) | 15 (3.5) | |
CCM score | ||||
≤ 2 | 216 (33.3) | 65 (28.8) | 151 (35.7) | 0.074 |
> 2 | 433 (66.7) | 161 (71.2) | 272 (64.3) | |
CKD | 67 (10.3) | 33 (14.6) | 34 (8.0) | 0.009 |
Recent NSAID use | 4 (0.6) | 0 (0) | 4 (0.9) | 0.14 |
Antiplatelet/coagulant use | 209 (32.2) | 86 (38.1) | 123 (29.1) | 0.02 |
Median duration of bleeding, days (IQR) | 1 (1–4) | 1 (1–3) | 2 (1–4) | 0.65 |